Abstract 13200: Changes in Thrombi-Inflammatory Biomarkers Associated With Therapeutic Heparin in Non-Critically Ill Patients Hospitalized With COVID-19: A Pre-Specified Secondary Analysis of the ACTIV4a and ATTACC Randomized Clinical Trial
Year: 2023
Type: conference-abstract
Source: Circulation
Authors: Lana Wahid, MD, Joshua Froess, Thomas L Ortel, Ryan Zarychanski, Michelle N Gong, Mary Cushman, Lucy Kornblith, Lana Castellucci, Michael E Farkouh, Ewan Gologher, Bryan J McVerry, Grant V Bochicchio, Abhijit Duggal, Yonatan Greenstein, Nicholas Hanna, Kristin Hudock, David T Huang, Robert Hyzy, Akram Khan, Vidya Krishnan, Matthew Kutcher, George Lim, Jose Luis Lopez-Sendon Moreno, Michael A Matthay, Ambarish Pandey, John Quigley, Lewis Satterwhite, Robert J Widmer, Jenny Jenny Wilson, Judith S Hochman, Jeffrey S Berger, Matthew D Neal, Patrick R Lawler
Institutions: Duke University, Duke Medical Center, University of Vermont, University of Pittsburgh, Cleveland Clinic, Rutgers, The State University of New Jersey, Rutgers New Jersey Medical School, University of California, Los Angeles, University of Illinois Chicago, Baylor Scott & White Medical Center - Temple
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4389957480